ClinicalTrials.govpublic full text
VAXZEVRIA Japan Post-Marketing Surveillance (PMS) for the Subjects With Underlying Disease at High-risk for Worsening COVID-19
prevention of infectious disease caused by sars-cov-2, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 858534
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.